AbbVie
ABBV
#35
Rank
$240.71 B
Marketcap
$136.44
Share price
-0.81%
Change (1 day)
-7.42%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - P/B ratio

P/B ratio as of May 2023 : 13.9

According to AbbVie's latest financial reports the company has a price-to-book ratio of 13.9.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

AbbVie - P/B ratio (from 2012 to 2022)

P/B ratio by year

Year P/B ratio Change
2022-12-3116.56.61%
2021-12-3115.57.36%
2020-12-3114.4-190.14%
2019-12-31-16.0-0.73%
2018-12-31-16.1-153.29%
2017-12-3130.337.99%
2016-12-3122.0-9.2%
2015-12-3124.2-59.56%
2014-12-3159.8220.35%
2013-12-3118.716.28%
2012-12-3116.0INF%
2011-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio differencediff. Country
2.18-84.36%๐Ÿ‡บ๐Ÿ‡ธ USA
35.9 158.00%๐Ÿ‡บ๐Ÿ‡ธ USA
21.8 56.84%๐Ÿ‡บ๐Ÿ‡ธ USA
3.13-77.50%๐Ÿ‡บ๐Ÿ‡ธ USA
4.55-67.36%๐Ÿ‡บ๐Ÿ‡ธ USA
4.20-69.86%๐Ÿ‡บ๐Ÿ‡ธ USA
6.19-55.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
4.95-64.48%๐Ÿ‡ฌ๐Ÿ‡ง UK
5.22-62.55%๐Ÿ‡บ๐Ÿ‡ธ USA